Short Bowel Syndrome (SBS) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

This reports provides a data-driven overview of the current and future competitive landscape in SBS therapeutics.

• There will be more than 94,000 diagnosed prevalent cases of SBS in 2023 in the 16 countries covered in GlobalData’s epidemiology forecast.
• Glucagon-like peptide 2 receptor agonists play a key role in the current treatment paradigm for SBS.
• R&D activity in SBS is promising with three drugs in Phase III development.
• The clinical trials space in SBS includes both commercial and academic sponsors, with the US emerging as a key country for conducting Phase III trials.
• Four strategic alliances involving companies developing SBS assets were successfully completed during the past two years.

Scope

GlobalData’s SBS: Competitive Landscape combines data from the Pharma Intelligence Center with in-house analyst expertise to provide a competitive assessment of the disease marketplace. _x000D_

_x000D_

Components of the report include:_x000D_

• Disease Landscape_x000D_

• Disease Overview_x000D_

• Epidemiology Overview_x000D_

• Treatment Overview_x000D_

• Marketed Products Assessment_x000D_

• Breakdown by Mechanism of Action, Molecule Type, Route of Administration_x000D_

• Product Profiles with Sales Forecast_x000D_

• Pricing and Reimbursement Assessment_x000D_

• Annual Therapy Cost_x000D_

• Time to Pricing and Time to Reimbursement_x000D_

• Pipeline Assessment_x000D_

• Breakdown by Development Stage, Mechanism of Action, Molecule Type, Route of Administration_x000D_

• Product Profiles with Sales Forecast_x000D_

• Late-to-mid-stage Pipeline Drugs_x000D_

• Phase Transition Success Rate and Likelihood of Approval_x000D_

• Clinical Trials Assessment_x000D_

• Breakdown of Trials by Phase, Status, Virtual Components, Sponsors, Geography, and Endpoint Status_x000D_

• Enrolment Analytics, Site Analytics, Feasibility Analysis_x000D_

• Deals Landscape_x000D_

• Mergers, Acquisitions, and Strategic Alliances by Region_x000D_

• Overview of Recent Deals_x000D_

• Commercial Assessment_x000D_

• Key Market Players_x000D_

• Future Market Catalysts

Reasons to Buy

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.

• Develop business strategies by understanding the trends shaping and driving the SBS market.

• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global SBS market in the future.

• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.

• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.

• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.